Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Merck stopping late stage study as another Alzheimers drug fails

      Merck stopping late stage study as another Alzheimer's drug fails

      supriya kashyap kashyap20 Feb 2017 11:35 AM IST
      Merck & Co Inc said it will halt a late-stage trial of an Alzheimer's drug after it was determined that it had no chance of working, marking the...
      Aetna CEO says Obamacare individual plans are in death spiral

      Aetna CEO says Obamacare individual plans are in death spiral

      supriya kashyap kashyap20 Feb 2017 11:31 AM IST
      Aetna Inc Chief Executive Mark Bertolini said the individual Obamacare exchanges are in a "death spiral" where rising premiums push out healthy...
      Trump

      Trump's pick to lead health agency calls EpiPen issue disturbing

      supriya kashyap kashyap20 Feb 2017 11:29 AM IST
      U.S. President Donald Trump's choice to lead an important health agency said that the way pharmaceutical companies classify products as generic or...
      Zydus Cadila receives USFDA nod to market fluconazole tablets

      Zydus Cadila receives USFDA nod to market fluconazole tablets

      supriya kashyap kashyap19 Feb 2017 11:29 AM IST
      New Delhi : Drug firm Zydus Cadila has received approval from the US health regulator to market fluconazole tablets used for the treatment of fungal...
      Sanofi Backtracked on Actelion Offer Price Amid J & J Talks

      Sanofi Backtracked on Actelion Offer Price Amid J & J Talks

      supriya kashyap kashyap19 Feb 2017 11:20 AM IST
      Turns out Sanofi’s proposal to buy Swiss biotechnology company Actelion Ltd. late last year wasn’t quite as compelling as it first seemed.Actelion, in...
      AiMED, Invest India ink MoU to promote Indian medical devices sector

      AiMED, Invest India ink MoU to promote Indian medical devices sector

      supriya kashyap kashyap19 Feb 2017 10:29 AM IST
      Singapore : In a bid to further provide an impetus to India's medical devices sector, The Association of Indian Medical Device Industry (AiMeD) has...
      Can Biocon, Mylan drugs be used for early breast cancer, asks Delhi HC

      Can Biocon, Mylan drugs be used for early breast cancer, asks Delhi HC

      supriya kashyap kashyap18 Feb 2017 3:02 PM IST
      New Delhi : Can pharma majors Biocon and Mylan's generic breast cancer drugs, similar to that of their competitor Roche, be prescribed for early...
      USFDA warns Bengaluru-based Resonance Labs of manufacturing norms violations

      USFDA warns Bengaluru-based Resonance Labs of manufacturing norms violations

      supriya kashyap kashyap18 Feb 2017 10:25 AM IST
      New Delhi : US health regulator USFDA has red-flagged significant deviations from manufacturing norms at the Bengaluru-based API facility of...
      Sun Pharma gets European Medicines Agency nod for Tobramycin

      Sun Pharma gets European Medicines Agency nod for Tobramycin

      supriya kashyap kashyap18 Feb 2017 10:24 AM IST
      New Delhi : Drug major Sun Pharmaceutical Industries said its subsidiary has received approval for Tobramycin from the European Medicines Agency.The...
      USFDA inspects Cadila Healthcares Moraiya facility

      USFDA inspects Cadila Healthcare's Moraiya facility

      supriya kashyap kashyap18 Feb 2017 10:23 AM IST
      New Delhi : Drug firm Cadila Healthcare said the US health regulator has inspected the company's Moraiya plant and found it meeting the manufacturing...
      Integra to buy J&Js Codman neurosurgery business for $1.05 billion

      Integra to buy J&J's Codman neurosurgery business for $1.05 billion

      supriya kashyap kashyap18 Feb 2017 9:23 AM IST
      Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in...
      Firms creating artificial shortage of stents, Govt Threatens Action

      Firms creating artificial shortage of stents, Govt Threatens Action

      supriya kashyap kashyap17 Feb 2017 5:06 PM IST
      New Delhi : Government said it is keeping a close watch on some companies trying to create an artificial shortage of life-saving coronary stents and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok